Russell Investments Group
BEAT

Russell Investments Group’s BioTelemetry, Inc. BEAT Stock Holding History

Russell Investments Group’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-207,523
Closed -$15M – 3281
2020
Q4 		$15M Sell
207,523
-75,370
-27% -$3.95M 0.03% 638
2020
Q3 		$12.9M Sell
282,893
-43,087
-13% -$1.8M 0.03% 646
2020
Q2 		$14.7M Sell
325,980
-82,413
-20% -$3.69M 0.03% 571
2020
Q1 		$15.7M Sell
408,393
-18,920
-4% -$871K 0.04% 478
2019
Q4 		$19.8M Buy
427,313
+48,682
+13% +$2.11M 0.04% 545
2019
Q3 		$15.4M Buy
378,631
+151,163
+66% +$6.53M 0.03% 648
2019
Q2 		$11M Sell
227,468
-38,212
-14% -$2.01M 0.02% 834
2019
Q1 		$16.6M Sell
265,680
-126,195
-32% -$8.67M 0.03% 647
2018
Q4 		$23.4M Sell
391,875
-155,937
-28% -$9.36M 0.05% 428
2018
Q3 		$35.3M Sell
547,812
-74,085
-12% -$4.13M 0.07% 329
2018
Q2 		$28M Sell
621,897
-178,454
-22% -$7.12M 0.06% 393
2018
Q1 		$24.9M Buy
800,351
+321,284
+67% +$10.6M 0.04% 508
2017
Q4 		$14.6M Sell
479,067
-391,658
-45% -$11.3M 0.02% 796
2017
Q3 		$28.7M Sell
870,725
-99,437
-10% -$3.44M 0.05% 455
2017
Q2 		$32.5M Buy
970,162
+519,267
+115% +$15.5M 0.06% 405
2017
Q1 		$13.1M Buy
450,895
+65,030
+17% +$1.61M 0.02% 738
2016
Q4 		$8.62M Buy
+385,865
New +$7.54M 0.02% 932

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Russell Investments Group's BEAT Position: Q1 2021 in Review

Russell Investments Group sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 207,523 shares — an estimated $15M sold.

Russell Investments Group first reported a position in BEAT in Q4 2016 and held it in 17 quarters. The position peaked at $35.3M in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Russell Investments Group reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Russell Investments Group sold 207,523 BioTelemetry, Inc. shares in Q1 2021, an estimated $15M.
  • Russell Investments Group first reported a position in BioTelemetry, Inc. in Q4 2016 and held it in 17 quarters.
  • Russell Investments Group's BioTelemetry, Inc. position peaked at $35.3M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Russell Investments Group's 13F filing for Q1 2021, filed 10 May 2021.